Cigna Corp (CI)

The Cigna Group is a U.S.-based healthcare company that provides insurance and related products and services through its subsidiaries. Its operations are organized into two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes pharmacy benefit and specialty care services such as claim adjudication, pharmacy network administration, benefit design support, utilization review, formulary management, home delivery pharmacy, specialty pharmacy, and clinical programs focused on health outcomes. Cigna Healthcare covers U.S. and international health businesses, with offerings that include employer medical plans, individual and family coverage, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, and global health solutions. The company also has other operations, including corporate-owned life insurance, reinsurance, and selected run-off and non-strategic businesses. It markets its products through brokers and consultants, as well as directly to employers, unions, groups, and individuals via private and public exchanges. Founded in 1792 and headquartered in Bloomfield, Connecticut, the company was formerly known as Cigna Corporation until its name change in February 2023.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CI
$437.34
52.5% Upside
Bargain
$340.92
18.9% Upside
Undervalued
Great
6.24
2.2%
July 30, 2026
12.1x
1.8x
0.3x
75.111 B
80.399 B
29.1%
99.5%
5.0
25.7%
121.8%
Valuation • Fair Value

Cigna Corp (NYSE-CI) Fair Value by Valuation Model

Compare the primary fair value estimate for Cigna Corp (NYSE-CI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$437.34

Estimated upside of 52.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$536.31

Discounted cash flow valuation reference.

Ben Graham Formula Value

$263.75

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$371.36

Comparable-company valuation reference.

Analyst Price Target

$340.92

Analysts imply upside of 18.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Cigna Corp (NYSE-CI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Cigna Corp (NYSE-CI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

277.9 B

Current operating scale indicator.

Revenue Forecast

283.5 B

Forward revenue estimate.

EBITDA

13.39 B

Current operating profitability reference.

EBITDA Forecast

13.565 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Cigna Corp (NYSE-CI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cigna Corp (NYSE-CI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.43

No elevated caution signal from this screen.

Altman Z-Score

5.0

Relatively strong balance-sheet zone.

FCF / Net Income

121.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cigna Corp (NYSE-CI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cigna Corp (NYSE-CI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.2%

Income yield reference.

Upcoming Dividend

6.24

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

25.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Cigna Corp (NYSE-CI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cigna Corp (NYSE-CI) Stock Forecast & Technical Outlook

Review Cigna Corp (NYSE-CI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Cigna Corp (NYSE-CI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Cigna Corp (NYSE-CI) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Cigna Corp (NYSE-CI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Cigna Corp (NYSE-CI) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Cigna Corp (NYSE-CI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cigna Corp (NYSE-CI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Cigna Corp (NYSE-CI) has a Strong Buy consensus, with 15 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 15
Hold 4
Sell 0
FAQ Fast Investor Answers

Cigna Corp (NYSE-CI) Stock FAQ

Quick answers about Cigna Corp (NYSE-CI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$437.34
Estimated upside 52.5%
Valuation Rating
Undervalued
Estimated upside of 52.5%
Analyst Target
$340.92
Implied upside 18.9%
Financial Health
Great
Current financial-health read

The current fair value estimate for Cigna Corp (NYSE-CI) is $437.34. This implies an estimated upside of 52.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 52.5% versus the current market price.

The available analyst price target for Cigna Corp (NYSE-CI) is $340.92. The analyst target implies estimated upside of 18.9%.

The current financial health read for Cigna Corp (NYSE-CI) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cigna Corp (NYSE-CI) is July 30, 2026.

Based on the current data, dividend yield is 2.2%, upcoming dividend amount is 6.24.

The current P/E ratio listed for Cigna Corp (NYSE-CI) is 12.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Cigna Corp is 75.111 B.

The current enterprise value listed for Cigna Corp is 80.399 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cigna Corp is NYSE-CI, and the stock is listed on NYSE.

Cigna Corp (NYSE-CI) is listed on NYSE.

The current debt-to-total-capital ratio listed for Cigna Corp is 29.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cigna Corp is 99.5%. Free float helps investors understand how much of the share base is available for public trading.